Eli Lilly starts trial of rheumatoid arthritis drug in COVID-19 patients

0
17
Eli Lilly and Co on Monday said it was launching a study of its rheumatoid arthritis drug baricitinib in patients hospitalized for COVID-19.

Go to Source
Author: